ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), characterized by lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth receptor 2 (HER2) amplification, harbors higher recurrence rate than non-TNBC counterparts1.